News
AUSTIN, Texas, Nov. 30, 2021 (GLOBE NEWSWIRE) -- Molecular Templates ... toxin bodies (ETBs), provided a corporate update and outlined expected 2022 milestones. “2021 was a year of growth ...
Milestone Pharmaceuticals Inc. (Nasdaq: MIST) today reported financial results for the second quarter ended June 30, 2024 and provided a regulatory and corporate update. “The FDA acceptance of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback